Head-to-head clinical Trial of Sofosbuvir plus Daclatasvir or Simeprevir for 12 weeks in Non-cirrhotic subjects with significant fibrosis infected with chronic Hepatitis C Virus genoType 1 (TNT-1 Study)
H. Pott Junior
◽
G. Bricks
◽
G. Grandi
◽
J. Senise
◽
A. Castelo
A Amanzada
◽
S Schneider
◽
F Moriconi
◽
M Blaschke
◽
T Suermann
◽
...
2019 ◽
Vol 26
(10)
◽
pp. 1229-1232
Tarik Asselah
◽
Stephen D. Shafran
◽
Stefan Bourgeois
◽
Ching‐Lung Lai
◽
Philippe Mathurin
◽
...
2015 ◽
Vol 62
(1)
◽
pp. 25-30
◽
Saleh A. Alqahtani
◽
Nezam Afdhal
◽
Stefan Zeuzem
◽
Stuart C. Gordon
◽
Alessandra Mangia
◽
...
2017 ◽
Vol 66
(1)
◽
pp. S3-S4
◽
X. Forns
◽
S. Lee
◽
J. Valdes
◽
S. Lens
◽
R. Ghalib
◽
...
2017 ◽
Vol 66
(1)
◽
pp. S519-S520
◽
J. Vermehren
◽
C. Athmann
◽
R. Günther
◽
E. Schott
◽
A. Pathil
◽
...
2016 ◽
Vol 166
(2)
◽
pp. 109
◽
Massimo Colombo
◽
Alessio Aghemo
◽
Hong Liu
◽
Jie Zhang
◽
Hadas Dvory-Sobol
◽
...
2019 ◽
Vol 26
(6)
◽
pp. 675-684
◽
Eric Lawitz
◽
Fred Poordad
◽
Leah J. Anderson
◽
Michelle Vesay
◽
Michelle M. Kelly
◽
...
2016 ◽
Vol 35
(12)
◽
pp. 1373
◽
Hagen Graf Einsiedel
◽
Holger Christiansen
◽
Johannes Wiegand
2016 ◽
Vol 64
(2)
◽
pp. 360-369
◽
Eric Lawitz
◽
Gary Matusow
◽
Edwin DeJesus
◽
Eric M. Yoshida
◽
Franco Felizarta
◽
...
Close
Export Citation Format
Close
Share Document
Close